You are here

Current Projects

 
  
 
Looking for a specific type of study? Finding the right fit is simple:
 1. Select your criteria below
 2. Press submit to view your results
 
  

The following projects are currently open and enrolling volunteers. These studies were evaluated and approved by the research team at Dr. Susan Love Research Foundation and members of our external Scientific Advisory Committee, comprised of researchers, clinicians, and advocates.

If you would like to learn about the studies we recruited for in the past, please click here.

  
Researcher: Seema Khan, MD, Northwestern University, Chicago, IL, Joseph Michael Guenther, MD, St. Elizabeth HealthCare, Edgewood, KY, Amy Degnim, MD, Mayo Clinic, Rochester, MN, Melissa Pilewskie, MD, Memorial Sloan Kettering Cancer Center, New York, NY, E. Shelley Hwang, MD, Duke University, Durham, NC, Stephen Grobmyer, MD, Cleveland Clinic, Cleveland, OH
Broadcast date: February 16, 2018

The purpose of this study is to compare the effects of tamoxifen pills to tamoxifen (4-OHT) gel on breast cells in women with ER+ DCIS. This study will investigate what effects each treatment has on the DCIS and what side effects each treatment may cause. The eventual goal is to provide women with DCIS with an alternative to oral tamoxifen.

Researcher: Laura Esserman, MD, MBA, University of California, San Francisco, CA and her partners from the Athena Breast Health Network (a collaboration across the five University of California Medical Centers and Sanford Health)
Broadcast date: February 16, 2018

Women receive mixed messages about what type of breast cancer screening they should have and how often they should have mammograms. The WISDOM Study compares the routine, annual mammogram schedule to a personalized screening schedule based on a woman’s individual risk factors. The goal of the study is to determine the best way to use mammograms to improve breast cancer screening while reducing the number of call backs, false alarms, and biopsies for women who do not have breast cancer.

Researcher: Jessica Gorman, PhD, Oregon State University, Corvallis
Broadcast date: February 9, 2018

The purpose of this research study is to gain insight into how young female cancer survivors communicate with their male partners and their healthcare providers about reproductive and sexual health after cancer. You and your partner will each take part in a 60 to 90-minute phone interview with a member of the research team. This research will contribute toward the development of an intervention to support couples struggling with reproductive and sexual health concerns after cancer.

Researcher: Tonia Poteat, PhD, and Lorraine T. Dean, ScD of Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Broadcast date: January 17, 2018

The purpose of this study is to learn about the best ways to improve access to breast cancer care and treatment for members of the Black LGBQ-SGL community. The research team will enroll up to 30 participants for an in-depth phone interview about identities and healthcare experiences.  

Researcher: Gwendolyn Thomas, PhD, Syracuse University, Syracuse, NY
Broadcast date: November 14, 2017

The purpose of this study is to learn what keeps breast cancer survivors from participating in physical activity, what levels of physical activity breast cancer survivors currently engage in, and what type of technology breast cancer survivors have access to and use daily. The researchers will use this information to develop an exercise app specifically for breast cancer survivors.

Researcher: Bernardine Pinto, Ph.D., Professor and Associate Dean of Research in the College of Nursing at the University of South Carolina, Columbia
Broadcast date: October 18, 2017

The purpose of this study is to test the effects of three physical activity programs among women with stage 0 to stage 3 breast cancer. This is a randomized controlled trial, therefore the research team is interested to see which program(s) help participants increase and maintain their level of physical activity. Survivors’ mood, fatigue, and quality of life will also be examined over the one-year duration.

Researcher: N. Lynn Henry, MD, PhD; Anna Beck, MD; Adam Cohen, MD; Saundra Buys, MD; John Ward, MD; Hung Khong, MD; Elizabeth Prystas, MD
Broadcast date: October 3, 2017

The purpose of this study is to better understand why some breast cancer survivors who have chronic pain and are treated with duloxetine will have their level of pain improve, while others will not. Women with breast cancer who have chronic pain will be asked to enroll. Participants will be treated with duloxetine for 7 weeks in order to determine how the medication affects both their level of pain and their sensitivity to pain. The research team hopes to understand more about why breast cancer survivors develop pain after their diagnosis and treatment, and why some people respond better to this type of treatment. The research team needs 56 women to participate in this study.  

Researcher: Ann Marie Flores, PT, PhD, CLT, Northwestern University
Broadcast date: September 27, 2017

The purpose of this study is to learn more about what breast cancer survivors age 65 and older know about the physical and functional impairments related to their breast cancer and its treatment. It will also help the research team understand what can be done to help people recover from breast cancer. This study is seeking 50 breast cancer survivors and 50 healthcare providers for a one-time, one-hour phone interview.

Para leer en español, por favor haga clic aquí

Researcher: Alexandra Zimmer, M.D., at the National Cancer Institute, Bethesda, MD
Broadcast date: September 20, 2017

The purpose of this study is to investigate whether using Temodar and Kadcyla together decreases the chance of patients with HER2+ metastatic breast cancer developing new brain metastases. Approximately 18 participants will take part in this study. Participants enrolled in this trial may be eligible to receive compensation for their travel expenses.

Researcher: Carolyn Westhoff, MD, Columbia University, New York, NY
Broadcast date: August 9, 2017

The purpose of this study is to learn how two different medications affect the breast: an estrogen-free selective progesterone-receptor modulator called UPA vs. a low-dose oral contraceptive pill. This is a randomized, phase I clinical trial. Participants have a 50% chance of receiving the UPA pill, and 50% chance of receiving the low-dose oral contraceptive.

Pages